Minoguard is a pharmaceutical company committed to the research and development of novel and improved combination treatment options that will potentially benefit millions of patients in the area of psychotic diseases.
MinoGuard has developed a unique technology for the identification, combination and maximization of the most efficient combination therapies for the treatment of these chronic disorders.
|
|
|